Asterab 40 DSR
Indication
Domperidone and Rabeprazole, marketed as Asterab 40 DSR capsules, combine rabeprazole 40mg and domperidone 30mg SR in a gastro-resistant and sustained-release formulation. This medication duo is specifically tailored for treating gastroesophageal reflux disease (GERD) and peptic ulcer disease.
Domperidone functions as a prokinetic agent, enhancing gastrointestinal motility to facilitate smoother movement of food through the stomach and intestines. This action reduces symptoms like bloating and nausea, and minimizes acid reflux by expediting gastric emptying.
Rabeprazole, a proton pump inhibitor (PPI), complements Domperidone's effects by reducing stomach acid production. By inhibiting the enzyme responsible for acid secretion, Rabeprazole decreases stomach acidity. This reduction is crucial in alleviating acid-related indigestion, heartburn, and promoting ulcer healing.
Asterab 40 DSR capsules provide a comprehensive approach to managing digestive disorders by targeting both acid regulation and gastrointestinal motility. This dual-action formulation offers effective symptom relief while supporting long-term digestive health and improved treatment outcomes.
Contraindication
Cough, Headache, Diarrhoea, Dizziness, Inflammation of the nose, abdominal pain, Vomiting, Weakness, Insomnia (difficulty in sleeping), Nausea, Constipation, Flatulence, Back pain, Pharyngitis.Storage
Cool & Dry Place
